KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea · Delayed Price · Currency is KRW

8,140.00

+100.00 (1.24%)

At close: Aug 14, 2026

KOREA PHARMA Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	91,417	87,601	81,277	83,240	81,029	79,577
Revenue Growth	11.78%	7.78%	-2.36%	2.73%	1.83%	11.28%
Gross Profit	31,586	31,372	35,150	36,903	35,415	35,898
Operating Income	-412.02	-887.33	6,086	5,840	6,187	5,014
Net Income	-2,473	-2,640	3,792	83.76	-1,119	6,368
Earnings Per Share	-226.93	-242.09	348.00	8.00	-103.00	579.00
EPS Growth	-	-	4250.00%	-	-	78.70%

Revenue by Geography

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
South Korea	77,976	79,794	77,605	76,365	68,180
Overseas	3,301	3,446	3,424	3,211	3,330

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	29,450	27,530	37,695	48,313	63,080	62,540
Total Debt	39,772	38,937	22,902	34,864	54,629	53,727
Net Cash (Debt)	-10,321	-11,408	14,793	13,449	8,451	8,813
Net Cash Growth	-	-	10.00%	59.13%	-4.11%	79.40%
Net Cash Per Share	-947.29	-953.91	1357.71	1284.46	777.88	801.30

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5,096	2,687	8,046	4,819	8,279	7,192
Capital Expenditures	-18,952	-19,644	-3,249	-1,531	-2,465	-2,552
Free Cash Flow	-13,857	-16,957	4,797	3,288	5,815	4,640
Free Cash Flow Growth	-	-	45.87%	-43.45%	25.31%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	34.55%	35.81%	43.25%	44.33%	43.71%	45.11%
Operating Margin	-0.45%	-1.01%	7.49%	7.02%	7.64%	6.30%
Pretax Margin	-4.67%	-5.16%	4.81%	2.42%	-2.20%	6.54%
Profit Margin	-2.71%	-3.01%	4.67%	0.10%	-1.38%	8.00%
FCF Margin	-15.16%	-19.36%	5.90%	3.95%	7.18%	5.83%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	44.04	3079.40	-	83.15
Forward PE	-	82.10	82.10	82.10	82.10	112.13
P/FCF Ratio	-	-	34.81	78.44	40.14	114.12
PS Ratio	0.97	1.62	2.05	3.10	2.88	6.65